Application progress of radiofrequency ablation in the treatment of early hepatocellular carcinoma

doi:10.3877/cma.j.issn.2095-2015.2021.05.010

Abstract

Abstract:

Currently, the most commonly selected treatments for early liver cancer are radiofrequency ablation(RFA), transcatheter arterial chemoembolization(TACE), and radical hepatectomy.Research in recent years has shown that RFA has the advantages of effectiveness, fewer complications, repeatable operations, short hospital stay and less cost, and is considered to be the first choice for the treatment of early focal liver cancer.But for a long period of time, RFA has a high tumor recurrence rate.This article summarizes the latest progress in the application of RFA in the treatment of focal liver cancer in recent years.

Key words: Earlyhepatocellular carcinoma, Radiofrequency ablation, Tumor recurrence, Combined therapy

Jiaying Li, Qiuli Zhang, Xiuli Zhang. Application progress of radiofrequency ablation in the treatment of early hepatocellular carcinoma[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2021, 11(05): 226-228.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxhbyyxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-2015.2021.05.010

https://zhxhbyyxzz.cma-cmc.com.cn/EN/Y2021/V11/I05/226

References 25

1	Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]．CA Cancer J Clin，2018，68(6):394-424.
2	Tashiro H, Aikata H, Waki K，et al.Treatment strategy for early hepatocellular carcinomas：comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection[J]．J Surg Oncol，2011，104(1):3-9.
3	Izzo F, Granata V, Grassi R, et al.Radiofrequency Ablation and Microwave Ablation in Liver Tumors：An Update[J]．Oncologist，2019，24(10):e990-e1005.
4	Jin S, Tan S, Peng W, et al.Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma：a systematic review and meta-analysis[J]．World J Surg Oncol，2020，18(1):199.
5	Ganne-Carrié N, Nault JC, Ziol M, et al.Predicting recurrence following radiofrequency percutaneous ablation for hepatocellular carcinoma[J]．Hepat Oncol，2014，1(4):395-408.
6	Harrison LE, Koneru B, Baramipour P, et al.Locoregional recur-rences are frequent after radiofrequency ablation for hepatocellular carcinoma[J]．J Am Coll Surg，2003，197(5):759-764.
7	Cohen GS, Black M．Multidisciplinary management of hepatocellular carcinoma：a model for therapy[J]．J Multidiscip Healthc，2013，6:189-95.
8	Wang F, Numata K, Nihonmatsu H, et al.Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation[J]．IntJ Hyperthermia，2020，37(1):1149-1158.
9	Li Q, Chen K, Huang W, et al.Minimally invasive photothermal ablation assisted by laparoscopy as an effective preoperative neoadjuvant treatment for orthotopic hepatocellular carcinoma[J]．Cancer Lett，2021，496:169-178.
10	Schullian P, Laimer G, Putzer D, et al.Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection[J]．Eur J Surg Oncol，2020，46(8):1503-1509.
11	Solbiati L, Ierace T, Gennaro N, et al.Percutaneous radiofrequency ablation of HCC：reduced ablation duration and increased ablation size using single，internally cooled electrodes with an optimized pulsing algorithm[J]．Int J Hyperthermia，2020，37(1):861-867.
12	Han TS, Ban HS, Hur K, et al.The Epigenetic Regulation of HCC Metastasis[J]．Int J Mol Sci，2018，19(12):3978.
13	Lassandro G, Picchi SG, Bianco A，et al.Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC：a five years study[J]．Med Oncol，2020，37(4):25.
14	Cui Y, Wu X, Lin C，et al.AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway[J]．Oncogene，2019，38(27):5516-5529.
15	Dong P, Wang X, Liu L，et al.Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma[J]．J Hepatol，2020，28:S0168-8278(20)30400-1.
16	Zhao M, Wang Y, Liu Y，et al.C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway[J]．Cancer Biol Ther，2019，20(12):1430-1442.
17	Greten TF, Manns MP, Korangy F．Immunotherapy of hepatocellular carcinoma[J]．J Hepatol，2006，45(6):868-878.
18	Rochigneux P, Nault JC, Mallet F, et al.Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinoma[J]．Oncoimmunology，2019，8(8):1615818.
19	Wu H, Li SS, Zhou M，et al.Palliative Radiofrequency Ablation Accelerates the Residual Tumor Progression Through Increasing Tumor-Infiltrating MDSCs and Reducing T-Cell-Mediated Anti-Tumor Immune Responses in Animal Model[J]．Front Oncol，2020，10:1308.
20	Bian H, Zheng JS, Nan G，et al.Randomized trial of [131I]metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation[J]．J Natl Cancer Inst，2014，106(9):dju239.
21	Duffy AG, Ulahannan SV, Makorova-Rusher O，et al.Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma[J]．J Hepatol，2017，66(3):545-551.
22	吴沛宏，陈奇峰，李旺．肝细胞癌微创与多学科综合诊疗——2018广州共识[J]．临床肝胆病杂志，2019，35(10):2176-2184.
23	Li H, Meng X, Zhang D, et al.Ginkgolic acid suppresses the invasion of HepG2 cells via downregulation of HGF/c-Met signaling[J]．Oncol Rep，2019，41(1):369-376.
24	Shao J, Shi CJ, Li Y，et al.LincROR Mediates the Suppressive Effects of Curcumin on Hepatocellular Carcinoma Through Inactivating Wnt/β-Catenin Signaling[J]．Front Pharmacol，2020，11:847.
25	Anwanwan D, Singh SK, Singh S, et al.Challenges in liver cancer and possible treatment approaches[J]．Biochim Biophys Acta Rev Cancer，2020，1873(1):188314.

[1]	Peng Tu, Xiaohang Zhang, Hongmei Dong, Gongli Chen, Suzhen Ran. Application value of ultrasound Doppler after radiofrequency ablation and fetal reduction for twin-to-twin transfusion syndrome [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(05): 492-497.
[2]	Lin Yan, Yu Lan, Fang Xie, Yukun Luo. Long-term clinical outcomes of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(02): 227-231.
[3]	Baofu Zhou, Lele Wu, Yonghong Li, Shichao Hu. Effect of different liver cutting methods in hepatectomy for multifocal primary liver cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2022, 16(03): 205-209.
[4]	Xing Wang, Fengwei Zhang. Clinical study of laparoscopic hepatectomy combined with radiofrequency ablation in the treatment of hepatocellular carcinoma with microvascular invasion [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 580-583.
[5]	Mingjie Song, Qinglei Han, Jialong Li, Yingmei Shao. Current status of endoscopic ablation for advanced extrahepatic bile duct malignancies [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 340-342.
[6]	Committee of Health Management for Organ Transplant Recipient, China Organ Transplantation Development Foundation, Branch of Organ Transplant Physicians of Chinese Medical Doctor Association, Branch of Organ Transplant of Chinese Medical Association, National Center for Healthcare Quality Management in Liver Transplant. Chinese expert consensus on clinical application of inhibitors of mammalian target of rapamycin in liver transplant recipients (2023 edition) [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(04): 193-204.
[7]	Haitao Zhang, Zhe Jia, Chao Ma, Qikun Zhang, Jushan Wu, Qingliang Guo, Daobing Zeng, Guangming Li, Menglong Wang. Comparison of clinical efficacy of liver resection and radiofrequency ablation for peripheral single small hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 523-527.
[8]	Hongyu Meng, Yi Lu, Yanlong Cao, Cao Dai, Jiawei Yang, Nan Lin, Jianliang Xu. Comparison of therapeutic effect between TACE combined with radiofrequency ablation and radiofrequency ablation alone for small liver cancer based on propensity score matching [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 417-421.
[9]	Xiaodong Wang, Kai Wang, Zhao Ge. Research progress of computer vision in improvement of therapeutic effect of liver transplantation for liver cancer [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(04): 361-366.
[10]	Yanbin Yu, Shouqin Dang, Yunlong Zhuang, Shiyou Xu, Lingzhan Meng, Peng Yu, Yuan Gao, Hu Li, Li Cao, Zhenyu Zhu. Diagnosis, treatment and efficacy of 35 patients with hepatic angiomyolipoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 327-330.
[11]	Zhuoqun Li, Fenggang Ren, Rongfeng Wang. Application progress of local therapy for cholangiocarcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(02): 153-156.
[12]	Qingjin Zeng, Liwen Zhao, Yuxuan Wu, Xuqi He, Lanxia Zhang, Xuan Yu, Na He, Rongqin Zheng, Kai Li. Clinical efficacy of ultrasound-guided percutaneous thermal ablation for malignant liver tumors adjacent to the heart [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(01): 49-54.
[13]	Fuwei Cheng, HaiPing Huang, Yuyu Niu, Jiachen Li, Peng Sun. Medium and long term outcomes of low temperature plasma radiofrequency ablation with microscopic suspension laryngoscopy for early glottic laryngeal cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(10): 995-999.
[14]	Nanjun Wang, Ningli Chai, Enqiang Linghu, Xiaotong Niu, Shengzhen Liu, Longsong Li, Wengang Zhang, Shasha Wang, Fei Gao. Clinical study on the management of patients with recurrent gastric low-grade intraepithelial neoplasia after endoscopic radiofrequency ablation [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2022, 09(04): 207-211.
[15]	Jianhui Ma, Ming Wen, Fang Xie, Qi Han. Application and satisfaction analysis of humanized nursing in radiofrequency ablation of patients with atrial fibrillation and gastroesophageal reflux [J]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2023, 10(01): 46-49.

Please choose a citation manager

Content to export